Literature DB >> 7508345

Common variable immunodeficiency: does life begin at 40?

P Lane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7508345      PMCID： PMC1534909          DOI： 10.1111/j.1365-2249.1994.tb06510.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  18 in total

Review 1.  Role of the CD28 receptor in T-cell activation.

Authors:  C H June; J A Ledbetter; P S Linsley; C B Thompson
Journal:  Immunol Today       Date:  1990-06

2.  T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes.

Authors:  Y Ron; J Sprent
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

Review 3.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

4.  Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency.

Authors:  M E North; A N Akbar; N Borthwick; K Sagawa; M Funauchi; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

5.  The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency.

Authors:  M B Fischer; H M Wolf; H Eggenbauer; V Thon; E Vogel; J Lokaj; J Litzman; J W Mannhalter; M M Eibl
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM.

Authors:  J P DiSanto; J Y Bonnefoy; J F Gauchat; A Fischer; G de Saint Basile
Journal:  Nature       Date:  1993-02-11       Impact factor: 49.962

Review 7.  Regulation of human B-cell activation and adhesion.

Authors:  E A Clark; P J Lane
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

8.  CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.

Authors:  R C Allen; R J Armitage; M E Conley; H Rosenblatt; N A Jenkins; N G Copeland; M A Bedell; S Edelhoff; C M Disteche; D K Simoneaux
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

9.  Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.

Authors:  P Lane; T Brocker; S Hubele; E Padovan; A Lanzavecchia; F McConnell
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.

Authors:  E A Ranheim; T J Kipps
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307
View more
  1 in total

1.  Serum soluble CD23 in patients with hypogammaglobulinaemia.

Authors:  A S Bansal; M R Haeney; S Cochrane; R S Pumphrey; L M Green; M Bhavnani; P B Wilson
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.